Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-28

Clinical Trial Update: Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer [Phase 1]

View source ↗

Summary

This completed Phase 1 trial evaluated a combination of vorinostat, irinotecan, fluorouracil, and leucovorin in patients with advanced upper gastrointestinal ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FLUOROURACIL (Fluorouracil)
  • Irinotecan (Irinotecan)
  • Leucovorin (folinic acid)
  • Vorinostat (vorinostat)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Esophageal Cancer, Gastric Cancer | Phase 1 | Status: COMPLETED